Of note, since MHC class II-mediated antigen presentation is mainly achieved by professional antigen presenting myeloid cells such as dendritic cells (DCs) and macrophages, but also B cells, CD4+ T cell-mediated immune responses do not require MHC class II expression on tumor cells. The gene discussed is CD4; the disease is neoplasm.